ITM secures 25M euros in a private equity funding round

2019 07 04 00 21 3668 Euros Bills 400

German radiopharmaceutical group ITM Isotope Technologies Munich has secured 25 million euros in a private equity funding round that it plans to put toward oncologic radioisotope research and development.

The funds add to ITM's coffers: In April, it announced a 90-million-euro convertible loan agreement.

The company's lead radioisotope candidate is Lu-177 Edotreotide, which is in a phase III trial for gastroenteropancreatic neuroendocrine tumors, it said.

Page 1 of 1249
Next Page